3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
113
Neoplasm Metastasis
5
Carcinoma, Intraductal, Noninfiltrating
5
Polycystic Ovary Syndrome
4
Ovarian Neoplasms
4
Osteoporosis
4
Neoplasms
4
Infertility
4
Breast Neoplasms, Male
4
Arthralgia
4
Fallopian Tube Neoplasms
3
Triple Negative Breast Neoplasms
2
Pain
2
Leiomyosarcoma
2
Leiomyoma
2
Endometrial Neoplasms
2
Cystadenocarcinoma, Serous
2
Breast Carcinoma In Situ
2
Bone Diseases, Metabolic
2
Advanced Breast Cancer
2
Uterine Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cysts
1
Osteitis Deformans
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Medullary cystic kidney disease 1
1
Lymphoma, Non-Hodgkin
1
Interventions
Carboplatin
25
Bevacizumab
18
Paclitaxel
17
Pemetrexed
16
Erlotinib Hydrochloride
14
Radiotherapy
12
Docetaxel
9
Gemcitabine
7
Cisplatin
6
ceritinib
5
Taxes
5
Cetuximab
5
pembrolizumab
3
pegfilgrastim
3
capmatinib
3
Surgical Procedures, Operative
3
Radiosurgery
3
Metformin
3
Gefitinib
3
Cyclophosphamide
3
Thalidomide
2
Sorafenib
2
Radiotherapy, Conformal
2
Nivolumab
2
Immunoglobulin G
2
Filgrastim
2
Disulfides
2
Albumin-Bound Paclitaxel
2
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma of Lung
×
Letrozole
×
Clear all
No trials found.